DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
SB-743921
1
Small molecule
Investigational
Unknown
Unknown
Hodgkin Disease; Lymphoma, Non-Hodgkin; Neoplasms
Unknown
SB-743921
×
Maximum Phase:
1
First Approval:
None
UNII:
24DSZ1VN92
Molecule Type:
Small molecule
Molecular Formula:
C31H33ClN2O3
Molecular Weight:
517.07
AlogP:
6.53
PSA:
76.54
HBD:
1.0
HBA:
#RotB:
9.0
Source:
CP-742,033
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CP-742,033
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LAVOLTIDINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LAVOLTIDINE
×
Maximum Phase:
1
First Approval:
None
UNII:
X16K5179V5
Molecule Type:
Small molecule
Molecular Formula:
C19H29N5O2
Molecular Weight:
359.47
AlogP:
2.17
PSA:
75.44
HBD:
2.0
HBA:
#RotB:
9.0
Source:
GSK-625433
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-625433
×
Maximum Phase:
1
First Approval:
None
UNII:
2YAD6KT0NT
Molecule Type:
Small molecule
Molecular Formula:
C26H32N4O5S
Molecular Weight:
512.63
AlogP:
4.02
PSA:
106.78
HBD:
1.0
HBA:
#RotB:
8.0
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BIIF 1149 BS
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BIIF 1149 BS
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARQ-621
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
ARQ-621
×
Maximum Phase:
1
First Approval:
None
UNII:
UU55190C8S
Molecule Type:
Small molecule
Molecular Formula:
C28H24Cl2FN5O2
Molecular Weight:
552.44
AlogP:
5.27
PSA:
93.25
HBD:
2.0
HBA:
#RotB:
9.0
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
OBP-801
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBP-801
×
Maximum Phase:
1
First Approval:
None
UNII:
30Q3VS5HZ4
Molecule Type:
Small molecule
Molecular Formula:
C20H31N3O6S2
Molecular Weight:
473.62
AlogP:
0.52
PSA:
133.83
HBD:
4.0
HBA:
#RotB:
1.0
Source:
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
L-ARABINOSE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
L-ARABINOSE
×
Maximum Phase:
1
First Approval:
None
UNII:
UO2PIV2K4C
Molecule Type:
Small molecule
Molecular Formula:
C5H10O5
Molecular Weight:
150.13
AlogP:
-2.58
PSA:
90.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
AGN-201904
1
Small molecule
Investigational
Unknown
Unknown
Peptic Ulcer
Unknown
AGN-201904
×
Maximum Phase:
1
First Approval:
None
UNII:
G0835O03ZM
Molecule Type:
Small molecule
Molecular Formula:
C25H25N3O8S2
Molecular Weight:
559.62
AlogP:
3.07
PSA:
146.91
HBD:
1.0
HBA:
#RotB:
10.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
NEMIRALISIB
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
PI3-kinase p110-delta subunit inhibitor
NEMIRALISIB
×
Maximum Phase:
1
First Approval:
None
UNII:
OEP8JJ3OZR
Molecule Type:
Small molecule
Molecular Formula:
C26H28N6O
Molecular Weight:
440.55
AlogP:
4.89
PSA:
76.98
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CEP-32496
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Epidermal growth factor receptor erbB1 inhibitor
CEP-32496
×
Maximum Phase:
1
First Approval:
None
UNII:
78I4VEX88N
Molecule Type:
Small molecule
Molecular Formula:
C24H22F3N5O5
Molecular Weight:
517.46
AlogP:
5.91
PSA:
120.63
HBD:
2.0
HBA:
#RotB:
7.0
Source:
INCB-057643
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
INCB-057643
×
Maximum Phase:
1
First Approval:
None
UNII:
87TZD0JEBS
Molecule Type:
Small molecule
Molecular Formula:
C20H21N3O5S
Molecular Weight:
415.47
AlogP:
2.07
PSA:
101.47
HBD:
1.0
HBA:
#RotB:
2.0
Source:
UC 781
1
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
UC 781
×
Maximum Phase:
1
First Approval:
None
UNII:
L7K247H29H
Molecule Type:
Small molecule
Molecular Formula:
C17H18ClNO2S
Molecular Weight:
335.86
AlogP:
5.37
PSA:
34.4
HBD:
1.0
HBA:
#RotB:
5.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KPT-9274
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin
Unknown
KPT-9274
×
Maximum Phase:
1
First Approval:
None
UNII:
9T56TV18X7
Molecule Type:
Small molecule
Molecular Formula:
C35H29F3N4O3
Molecular Weight:
610.64
AlogP:
7.08
PSA:
101.46
HBD:
2.0
HBA:
#RotB:
7.0
Source:
GLUMETINIB
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
GLUMETINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
7JTT036WGX
Molecule Type:
Small molecule
Molecular Formula:
C21H17N9O2S
Molecular Weight:
459.5
AlogP:
2.12
PSA:
117.79
HBD:
0.0
HBA:
#RotB:
4.0
Source:
N-ACETYLGLUCOSAMINE
1
Small molecule
Investigational
Unknown
Unknown
Malnutrition
Unknown
N-ACETYLGLUCOSAMINE
×
Maximum Phase:
1
First Approval:
None
UNII:
8P59336F68
Molecule Type:
Small molecule
Molecular Formula:
C8H15NO6
Molecular Weight:
221.21
AlogP:
-3.08
PSA:
119.25
HBD:
5.0
HBA:
#RotB:
2.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
RG-7603
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin
Serine/threonine-protein kinase mTOR inhibitor
RG-7603
×
Maximum Phase:
1
First Approval:
None
UNII:
579255I6O9
Molecule Type:
Small molecule
Molecular Formula:
C24H32N6O3
Molecular Weight:
452.56
AlogP:
2.27
PSA:
91.85
HBD:
2.0
HBA:
#RotB:
5.0
Source:
ASP-4058
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASP-4058
×
Maximum Phase:
1
First Approval:
None
UNII:
01J7526K2Q
Molecule Type:
Small molecule
Molecular Formula:
C19H12F6N4O2
Molecular Weight:
442.32
AlogP:
5.63
PSA:
76.83
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GSK2879552
1
Small molecule
Investigational
Unknown
Unknown
Leukemia; Myelodysplastic Syndromes; Small Cell Lung Carcinoma
Unknown
GSK2879552
×
Maximum Phase:
1
First Approval:
None
UNII:
GT77Z6Y09Z
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O2
Molecular Weight:
364.49
AlogP:
3.74
PSA:
52.57
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TEMANOGREL
1
Small molecule
Investigational
Unknown
Unknown
Acute Coronary Syndrome
Serotonin 2a (5-HT2a) receptor inverse agonist
TEMANOGREL
×
Maximum Phase:
1
First Approval:
None
UNII:
F42Z27575A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N4O4
Molecular Weight:
436.51
AlogP:
3.06
PSA:
77.85
HBD:
1.0
HBA:
#RotB:
8.0
Source:
Y-39983
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Rho-associated protein kinase inhibitor
Y-39983
×
Maximum Phase:
1
First Approval:
None
UNII:
00ALI1GAY2
Molecule Type:
Small molecule
Molecular Formula:
C16H16N4O
Molecular Weight:
280.33
AlogP:
2.83
PSA:
83.8
HBD:
3.0
HBA:
#RotB:
3.0
Source:
AZD-5991
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
AZD-5991
×
Maximum Phase:
1
First Approval:
None
UNII:
E3T5XXY9HX
Molecule Type:
Small molecule
Molecular Formula:
C35H34ClN5O3S2
Molecular Weight:
672.28
AlogP:
8.18
PSA:
87.1
HBD:
1.0
HBA:
#RotB:
1.0
Source:
FLUOCINOLONE
1
Small molecule
Investigational
Unknown
Unknown
Wet Macular Degeneration
Unknown
FLUOCINOLONE
×
Maximum Phase:
1
First Approval:
None
UNII:
CT1IX58L9S
Molecule Type:
Small molecule
Molecular Formula:
C21H26F2O6
Molecular Weight:
412.43
AlogP:
0.57
PSA:
115.06
HBD:
4.0
HBA:
#RotB:
2.0
Source:
SALCAPROZIC ACID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SALCAPROZIC ACID
×
Maximum Phase:
1
First Approval:
None
UNII:
X88E147FCU
Molecule Type:
Small molecule
Molecular Formula:
C15H21NO4
Molecular Weight:
279.34
AlogP:
2.55
PSA:
86.63
HBD:
3.0
HBA:
#RotB:
9.0
Source:
BLU-782
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BLU-782
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C31H42N6O4
Molecular Weight:
562.72
AlogP:
4.18
PSA:
84.67
HBD:
0.0
HBA:
#RotB:
7.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
1
2
…
68
69
70
71
72
73
74
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA